SAM
MRVI icon

Smartleaf Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Smartleaf Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51
Closed -$120 – 2885
2025
Q1 		$120 Sell
51
-398
-89% -$1.57K ﹤0.01% 2834
2024
Q4 		$2.47K Buy
449
+59
+15% +$380 ﹤0.01% 2475
2024
Q3 		$3.28K Buy
390
+236
+153% +$2.04K ﹤0.01% 2302
2024
Q2 		$1.09K Buy
+154
New +$1.33K ﹤0.01% 2400

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Smartleaf Asset Management's MRVI Position: Q2 2025 in Review

Smartleaf Asset Management sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 51 shares — an estimated $120 sold.

Smartleaf Asset Management first reported a position in MRVI in Q2 2024 and held it in 4 quarters. The position peaked at $3.28K in Q3 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Smartleaf Asset Management reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Smartleaf Asset Management sold 51 Maravai LifeSciences shares in Q2 2025, an estimated $120.
  • Smartleaf Asset Management first reported a position in Maravai LifeSciences in Q2 2024 and held it in 4 quarters.
  • Smartleaf Asset Management's Maravai LifeSciences position peaked at $3.28K in Q3 2024.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Smartleaf Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.